To save researchers time and resources, The Michael J. Fox Foundation has made a number of tools available to the scientific community at low cost, with rapid delivery.
Helpful Resources
-
Sponsored Tools Program
Learn more about how MJFF can help share your tools.
-
Tools Consortium
MJFF is working with industry to develop priority tools.
-
Preclinical Models
Learn more about the various in vivo models used in Parkinson's disease research.
Find a Research Tool
Filter by Tool Type or Gene/Protein Type to Organize Results
* = MJFF does not control pricing or terms of availability for this tool.
Filters
LRRK2 G2019S KI MEF
Immortalized Cell
Mouse embryonic fibroblast line with knockin of the LRRK2 G2019S mutation. This cell line failed development due to instability of LRRK2 upon editing.
LRRK2 R1441G KI MEF
Immortalized Cell
Mouse embryonic fibroblast line with knockin of the LRRK2 R1441G mutation. This cell line failed development due to LRRK2 instability upon editing.
LRRK2 pS1292 Phosphospecific Antibody
Antibody
Rabbit monoclonal antibody directed against human/mouse LRRK2 phosphorylation at Serine1292 (pS1292 LRRK2). Developed for use in immunoblotting and immunoassay applications. Anticipated Availability: Q4 2027
NOD2 Antibody
Antibody
Rabbit monoclonal antibody directed against human/mouse NOD2. Developed for use in immunoblotting, immunocytochemistry, and immunohistochemistry applications. This antibody development project is part of the MJFF Targets to Therapies (T2T) Initiative. Anticipated Availability: Q4 2027
PPM1M Antibody
Antibody
Rabbit monoclonal antibody directed against human PPM1M. Developed for use in immunoblotting and immunocytochemistry applications. Anticipated Availability: Q4 2027
Rab13 pS111 Phosphospecific Antibody
Antibody
Rabbit monoclonal antibody directed against human Rab13 when phosphorylated at Serine111 (pS111 Rab13). Developed for use in immunoblotting, immunocytochemistry and immunoassay applications. Anticipated Availability: Q4 2027
Rab13 Antibody
Antibody
Rabbit monoclonal antibody directed against human Rab13. Developed for use in immunoblotting, immunocytochemistry, and immunoassay applications. Anticipated Availability: Q4 2027
Rab21 Antibody
Antibody
Rabbit monoclonal antibody directed against human Rab21. Developed for use in immunoblotting and immunocytochemistry applications. Anticipated Availability: Q4 2027
SLC18B1 Antibody
Antibody
Rabbit monoclonal antibody directed against human SLC18B1. Developed for use in immunoblotting, immunocytochemistry, and immunoprecipitation applications. This antibody development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative. Anticipated Availability: Q4 2027
SPTSSB Antibody
Antibody
Rabbit monoclonal antibody directed against human SPTSSB. Developed for use in immunoblotting, immunocytochemistry, and immunoprecipitation applications. This antibody development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative. Anticipated Availability: Q4 2027
Have questions or need additional information?
Email tools@michaeljfox.org with questions and to suggest new tools for us to develop. Or visit our FAQ page.
"We have shown, thanks in part to MJFF, that researchers now have in their pantry the right ‘ingredients’, to... help to drive forward PD drug development.”
Heather Melrose, PhD
Mayo Clinic